Importance of the renin-angiotensin system in the generation of kidney failure in renovascular hypertension

Journal of Hypertension

Volumn 14, Issue 9, 1996, Pages 1131-1137

  Abdi, Asghar ^a   Johns, Edward J ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Acute renal failure; Angiotensin converting enzyme inhibition; Renovascular hypertension; Sodium depletion

Indexed keywords

ANGIOTENSIN; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; SODIUM; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CREATININE BLOOD LEVEL; DIETARY INTAKE; FLUID INTAKE; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SODIUM EXCRETION; SODIUM INTAKE; UREA BLOOD LEVEL;

EID: 0029764331     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199609000-00014     Document Type: Article

References (22)

1. Hall JE, Guyton AC: Control of sodium excretion and arterial pressure by intrarenal mechanisms and the renin-angiotensin system. In Hypertension: Pathophysiology, Diagnosis and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:1105-1130.
2. Johns EJ: Role of angiotensin II and the sympathetic nervous system in the control of renal function. J Hypertens 1989, 7:695-701.
3. Edwards RM: Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 1983, 244:F526-F543.
4. Carmines PK, Morrison TK, Navar LG: Angiotensin II effects on microvascular diameter of in vitro blood perfused juxtamedullary nephrons. Am J Physiol 1986, 251:F610-F618.
5. Denton KM, Fennessy PA, Alcorn D, Anderson WP: Morphometric analysis of angiotensin II on renal arterioles and glomeruli. Am J Physiol 1992, 262:F367-F372.
6. Jackson B, Matthews PG, Migrath BP, Johnston CI: Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Lancet 1984, i:225-226.
7. Chrysant SG, Dunn NJ, Marples D, De Masters K: Severe reversible azotaemia from captopril therapy. Arch Intern Med 1983, 143:437-441.
8. Hirick DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ: Captopril induced functional renal insufficiency in patients with bilateral renal artery stenosis or renal artery stenosis in a solitary kidney. N Engl J Med 1983, 308:373-376.
9. Johnston CI, Jackson B: Overview: angiotensin converting enzyme inhibition in renovascular hypertension. Kidney Int 1987, 31: S154-S156.
10. Helmchen U, Grone HJ, Kirchertz EJ, Rader H, Bohle RM, Kneissler U, et al.: Contrasting renal effects of different antihypertensive agents in hypertensive rats with bilaterally constricted renal arteries. Kidney Int 1982, 22 (suppl 12):S198-S205.
11. Walser M, Drew HH, Guildan JL: Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. Kidney Int 1993, 44:1145-1148.
12. Schuster VL, Seldin DW: Renal clearance. In The Kidney: Physiology and Pathophysiology. Edited by Seldin DW, Giebisch G. New York: Raven Press; 1992:943-978.
13. Chamienia AL, Johns EJ: The interaction between atrial natriuretic peptides and angiotensin Il in controlling sodium and water excretion in the rat. Br J Pharmacol 1991, 103:1893-1898.
14. Al-Qattan KK, Johns EJ: A comparison of the actions of cilazapril in normal, dietary sodium depleted and 2K1C Goldblatt hypertensive anaesthetized rats. J Hypertens 1992, 10:423-429.
15. Wong PC, Hart SD, Duncia JV, Timmermans PBMWM: Non-peptide angiotensin antagonists XIII: studies with DUP 753 and EXP 3174 in dogs. Eur J Pharmacol 1991, 20:323-330.
16. Cogan MG: Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990, 15:451-458.
17. Sen S, Smeby RS, Bumpus FM, Turcotte JG: Role of the renin-angiotensin system in chronic renal hypertensive rats. Hypertension 1979, 1:427-434.
18. Tobian L, Coffee K, MacCrea P: Contrasting exchangeable sodium in rats with different types of Goldblatt hypertension. Am J Physiol 1969, 217:458-460.
19. Swales JD, Thuston H, Queroz FP, Medina A: Sodium balance during the development of experimental hypertension. J Lab Clin Med 1972, 80: 539-547.
20. Wenting GJ, Derkk FHM, Tan-Tjiong LH, Seyen AJV, Veld AJMI, Schalekamp MADH: Risks of angiotensin converting enzyme inhibition in renal artery stenosis. Kidney Int 1987, 31 (suppl 20):S180-S183.
21. Brunner HR: ACE inhibitors in renal disease. Kidney Int 1992, 42: 463-479.
22. Basso N, Kurnjek ML, Ruiz P, Cannata MA: Effects of EXP 3174 on blood pressure of normoreninemic renal hypertensive rats. Hypertension 1995, 25:283-287.